查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386334

急性脊髓損傷市場報告：2030 年趨勢、預測與競爭分析

Acute Spinal Cord Injury Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

急性脊髓損傷的趨勢和預測

預計到 2030 年，全球急性脊髓損傷市場將達到約 96 億美元，2024 年至 2030 年複合年成長率為 5.6%。該市場的主要促進因素是人們對早期治療益處的認知不斷提高、急性脊髓損傷患病率上升以及極限運動活動在全球範圍內日益普及。全球急性脊髓損傷市場的未來充滿希望，醫院和創傷中心市場充滿機會。

急性脊髓損傷市場洞察

Lucintel 預測，由於脊髓損傷盛行率不斷增加以及人們對脊髓損傷治療的認知不斷增強，不完全性脊髓損傷 (ISCI) 在預測期內將繼續佔據較大佔有率。

由於醫院住院復健計畫的增加以及提供幫助人們的綜合服務，預計醫院將繼續佔據該市場的很大一部分。

由於人口迅速高齡化、發達的醫療保健系統以及先進技術的採用增加，預計北美仍將是最大的地區。

市場規模/估計：以金額估計急性脊髓損傷的市場規模（十億美元）。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

區隔市場分析：依類型、最終用途和金額估算急性脊髓損傷市場規模（十億美元）。

區域分析：北美、歐洲、亞太地區和世界其他地區的急性脊髓損傷市場區隔。

成長機會：急性脊髓損傷市場依類型、最終用途和區域進行的成長機會分析。

策略分析：急性脊髓損傷市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球急性脊髓損傷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球急性脊髓損傷市場趨勢（2018-2023）與預測（2024-2030）
  • 依類型分類的全球急性脊髓損傷市場
    • 完全性脊髓損傷
    • 不完全性脊髓損傷
  • 依最終用途分類的全球急性脊髓損傷市場
    • 醫院
    • 創傷中心

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球急性脊髓損傷市場（依地區）
  • 北美急性脊髓損傷市場
  • 歐洲急性脊髓損傷市場
  • 亞太地區急性脊髓損傷市場
  • 其他地區急性脊髓損傷市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依類型分類的全球急性脊髓損傷市場成長機會
    • 全球急性脊髓損傷市場成長機會（依最終用途）
    • 全球急性脊髓損傷市場成長機會（依地區）
  • 全球急性脊髓損傷市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球急性脊髓損傷市場的產能
    • 全球急性脊髓損傷市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Novartis
  • Tenax Therapeutics
  • Accure Pharma
  • Acorda Therapeutics
  • Asterias Biotherapeutics
  • ReNetX Bio
  • BioArctic
  • BioTime
  • InVivo Therapeutics
  • Kringle Pharma
簡介目錄

Acute Spinal Cord Injury Trends and Forecast

The future of the global acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets. The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

A more than 150-page report is developed to help in your business decisions.

Acute Spinal Cord Injury by Segment

The study includes a forecast for the global acute spinal cord injury by type, end use, and region.

Acute Spinal Cord Injury Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Complete Spinal Cord Injury
  • Incomplete Spinal Cord Injury

Acute Spinal Cord Injury Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Trauma Centers

Acute Spinal Cord Injury Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Acute Spinal Cord Injury Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acute spinal cord injury companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acute spinal cord injury companies profiled in this report include-

  • Novartis
  • Tenax Therapeutics
  • Accure Pharma
  • Acorda Therapeutics
  • Asterias Biotherapeutics
  • Renetx Bio
  • Bioarctic
  • Biotime
  • Invivo Therapeutics
  • Kringle Pharma

Acute Spinal Cord Injury Market Insights

Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Within this market, hospital is expected to remain the larger segment due to growing number of inpatient rehabilitation programs at hospitals to deliver comprehensive services to help people.

North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Features of the Global Acute Spinal Cord Injury Market

Market Size Estimates: Acute spinal cord injury market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acute spinal cord injury market size by type, end use, and region in terms of value ($B).

Regional Analysis: Acute spinal cord injury market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the acute spinal cord injury market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acute spinal cord injury market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the acute spinal cord injury market size?

Answer: The global acute spinal cord injury market is expected to reach an estimated $9.6 billion by 2030.

Q.2 What is the growth forecast for acute spinal cord injury market?

Answer: The global acute spinal cord injury market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the acute spinal cord injury market?

Answer: The major drivers for this market are growing awareness towards the benefits of early treatment, rising incidence of acute spinal cord injury, and growing popularity of extreme sports activities across the globe.

Q4. What are the major segments for acute spinal cord injury market?

Answer: The future of the acute spinal cord injury market looks promising with opportunities in the hospital and trauma center markets.

Q5. Who are the key acute spinal cord injury market companies?

Answer: Some of the key acute spinal cord injury companies are as follows:

  • Novartis
  • Tenax Therapeutics
  • Accure Pharma
  • Acorda Therapeutics
  • Asterias Biotherapeutics
  • Renetx Bio
  • Bioarctic
  • Biotime
  • Invivo Therapeutics
  • Kringle Pharma

Q6. Which acute spinal cord injury market segment will be the largest in future?

Answer: Lucintel forecasts that incomplete spinal cord injury (ISCI) will remain the larger segment over the forecast period due to increasing incidence of spinal cord injuries and growing awareness towards treatment of spinal cord injuries.

Q7. In acute spinal cord injury market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to surge in aging population, well-developed healthcare system, and increasing adoption of advanced technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the acute spinal cord injury market by type (complete spinal cord injury and incomplete spinal cord injury), end use (hospitals and trauma centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acute Spinal Cord Injury Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Acute Spinal Cord Injury Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Acute Spinal Cord Injury Market by Type
    • 3.3.1: Complete Spinal Cord Injury
    • 3.3.2: Incomplete Spinal Cord Injury
  • 3.4: Global Acute Spinal Cord Injury Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Trauma Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Acute Spinal Cord Injury Market by Region
  • 4.2: North American Acute Spinal Cord Injury Market
    • 4.2.2: North American Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
  • 4.3: European Acute Spinal Cord Injury Market
    • 4.3.1: European Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
    • 4.3.2: European Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
  • 4.4: APAC Acute Spinal Cord Injury Market
    • 4.4.1: APAC Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
    • 4.4.2: APAC Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers
  • 4.5: ROW Acute Spinal Cord Injury Market
    • 4.5.1: ROW Acute Spinal Cord Injury Market by Type: Complete Spinal Cord Injury and Incomplete Spinal Cord Injury
    • 4.5.2: ROW Acute Spinal Cord Injury Market by End Use: Hospitals and Trauma Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Type
    • 6.1.2: Growth Opportunities for the Global Acute Spinal Cord Injury Market by End Use
    • 6.1.3: Growth Opportunities for the Global Acute Spinal Cord Injury Market by Region
  • 6.2: Emerging Trends in the Global Acute Spinal Cord Injury Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Acute Spinal Cord Injury Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acute Spinal Cord Injury Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Novartis
  • 7.2: Tenax Therapeutics
  • 7.3: Accure Pharma
  • 7.4: Acorda Therapeutics
  • 7.5: Asterias Biotherapeutics
  • 7.6: ReNetX Bio
  • 7.7: BioArctic
  • 7.8: BioTime
  • 7.9: InVivo Therapeutics
  • 7.10: Kringle Pharma